The U.S. Food and Drug Administration (FDA) is reviewing two emergency use authorization requests for COVID-19 vaccines, with an outside advisory committee scheduled to meet next Thursday to review data from Pfizer and its German partner BioNTech.
Axios Re:Cap digs in with former FDA commissioner Rob Calif about the EUA process, the science and who should make the final call.
